Compressive Optic Neuropathy 

  • Author: Jonathan W Kim, MD; Chief Editor: Hampton Roy Sr, MD   more...
 
Updated: Oct 19, 2011
 

Background

The optic nerve contains retinal ganglion cell axons that extend posteriorly from the globe, through the orbit and optic canal, to reach the optic chiasm. The total length of the optic nerve averages 50 mm: 1 mm for the intraocular segment, 25 mm for the intraorbital segment, 10 mm for the intracanalicular segment, and 14 mm for the intracranial segment. An injury to the optic nerve anywhere along this pathway by an extrinsic lesion is termed compressive optic neuropathy (CON). The optic nerve is most vulnerable to injury by a compressive force where it is adjacent to bone or in a confined space (eg, orbital apex, optic canal).[1]

The clinical hallmark of compressive optic neuropathy is slowly progressive vision loss. Characteristic findings on clinical examination include reduced visual acuity, dyschromatopsia, a relative afferent pupillary defect, visual field defect, and optic atrophy (or edema). A delay in the diagnosis of compressive optic neuropathy is not uncommon since the vision loss is insidious, and the clinical findings may be missed or misinterpreted as a cataract, maculopathy, glaucoma, or optic neuritis.

Clinicians should consider compressive optic neuropathy in the differential diagnosis of unexplained, asymmetric visual acuity, normal or low-tension glaucoma, or visual symptoms responsive to corticosteroids. Similarly, a workup of incidentally discovered optic atrophy should include a neuroimaging study (eg, magnetic resonance imaging) to rule out a compressive lesion. The management of compressive optic neuropathy is often difficult, given the proximity of compressive lesions to critical neurovascular structures in the orbit and intracranial space. Many of the conditions causing compressive optic neuropathy are also resistant to radiotherapy at doses tolerated by the globe and anterior visual pathways.

Next

Pathophysiology

Optic nerve compression by an extrinsic lesion has been postulated to cause atrophy of ganglion cell axons either through ischemia or mechanical disruption of axonal transport. Rarely, an intrinsic lesion of the optic nerve (ie, optic nerve glioma) can cause damage to the individual axons due to slow compression of the fascicles within the tumor.

Previous
Next

Epidemiology

Frequency

United States

Compared to other ophthalmic conditions, compressive optic neuropathy (CON) is relatively rare, with an estimated incidence of about 4 cases per 100,000 individuals per year. The majority of cases encountered in clinical practice are due to Graves' orbitopathy, with compression of the optic nerve by the enlarged extraocular muscles at the orbital apex.[2]

Mortality/Morbidity

  • Compressive optic neuropathy (CON) typically causes permanent vision loss, particularly if optic atrophy is evident at the time of diagnosis. However, with certain conditions such as Graves' orbitopathy and pituitary adenomas, significant visual recovery may occur after surgical intervention.[3]
  • When CON is due to a malignant lesion, the patient's systemic prognosis may be affected.
  • Tumors compressing the optic nerve in the intracranial space may cause additional neurologic morbidity (eg, endocrine dysfunction, cranial nerve palsies, papilledema, stroke).
  • Tumors within the orbit causing CON may cause disfiguring proptosis and permanent diplopia.[2]
  • Treatment of CON may have serious side effects, ranging from profound vision loss (surgery-induced ischemia or radiation toxicity) to permanent brain injury (eg, stroke, radionecrosis).

Sex

There is no sex predilection for CON with the exception of Graves' orbitopathy and meningiomas, two conditions which are more common in women than in men.

Age

Compressive optic neuropathy (CON) may occur at any age, but it is more common after age 30 years. In children, CON is typically caused by optic nerve glioma or rhabdomyosarcoma.[4]

Previous
 
 
Contributor Information and Disclosures
Author

Jonathan W Kim, MD  Director of Oculoplastic and Orbital Surgery, Co-director of Ocular Oncology Service, Co-director of Neuro-ophthalmology Service, Department of Ophthalmology, Stanford Medical Center

Jonathan W Kim, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Ophthalmology, American Society of Ophthalmic Plastic and Reconstructive Surgery, and North American Neuro-Ophthalmology Society

Disclosure: Nothing to disclose.

Coauthor(s)

Diana Katherine Lee  Fellow, Cancer Research Training Award; National Institutes of Health, National Cancer Institute

Disclosure: Nothing to disclose.

Talmadge (Ted) Cooper, MD  Adjunct Clinical Associate Professor, Department of Ophthalmology, Stanford Medical School

Talmadge (Ted) Cooper, MD is a member of the following medical societies: American Academy of Ophthalmology and American College of Medical Informatics

Disclosure: Nothing to disclose.

Specialty Editor Board

Edsel Ing, MD, FRCSC  Associate Professor, Department of Ophthalmology and Vision Sciences, University of Toronto Faculty of Medicine; Consulting Staff, Toronto East General Hospital, Canada

Edsel Ing, MD, FRCSC is a member of the following medical societies: American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, American Society of Ophthalmic Plastic and Reconstructive Surgery, Canadian Ophthalmological Society, North American Neuro-Ophthalmology Society, and Royal College of Physicians and Surgeons of Canada

Disclosure: Nothing to disclose.

Simon K Law, MD, PharmD  Associate Professor of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, David Geffen School of Medicine

Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Association for Research in Vision and Ophthalmology

Disclosure: Nothing to disclose.

Brian R Younge, MD  Professor of Ophthalmology, Mayo Clinic School of Medicine

Brian R Younge, MD is a member of the following medical societies: American Medical Association, American Ophthalmological Society, and North American Neuro-Ophthalmology Society

Disclosure: Nothing to disclose.

Lance L Brown, OD, MD  Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri

Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD  Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

References
  1. Miller NR, Newman NJ, Biousse V. Walsh and Hoyt's Clinical Neuro-Ophthalmology. 6th ed. Lippincott, Williams & Wilkins; 2004.

  2. Schiefer U, Wilhelm H, Hart W. Neuro-ophthalmic presentations of orbital disease. In: Clinical Neuro-Ophthalmology: A Practical Guide. Wien & New York: Springer; 2007.

  3. Bulters DO, Shenouda E, Evans BT, Mathad N, Lang DA. Visual recovery following optic nerve decompression for chronic compressive neuropathy. Acta Neurochir (Wien). Apr 2009;151(4):325-34. [Medline].

  4. Shields AJ, Shields CL, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: the 2002 Montgomery Lecture, Part 1. Ophthalmology. 2004;111(5):997-1008. [Medline].

  5. Hodson KE, Bowman RJ, Mafwiri M, et al. Low folate status and indoor pollution are risk factors for endemic optic neuropathy in Tanzania. Br J Ophthalmol. Oct 2011;95(10):1361-4. [Medline].

  6. Lee AG, Chau FY, Golnik KC, Kardon RH, Wall M. The diagnostic yield of the evaluation for isolated unexplained optic atrophy. Ophthalmology. May 2005;112(5):757-9. [Medline].

  7. Spoor TC. Atlas of Oculoplastic and Orbital Surgery. Informa Healthcare; 2007.

Previous
Next
 
Axial MRI taken 3 weeks after the onset of distorted vision in the right eye; visual acuity is reduced to counting fingers at 1 ft. Evidence of optic nerve compression is not seen; disease in the sphenoid sinus is reported.
MRI of same patient as in the image above taken 4 months later. Patient responded well to IV Solu-Medrol, but symptoms returned when steroids were reduced. Large mass compressing the right optic nerve is seen. Biopsy revealed lymphoma.
A 72-year-old man with a moderate decrease in vision in the left eye (20/20 right, 20/25 left). Fundus examination revealed a normal right optic nerve.
Same patient as in image above of a 72-year-old man with a moderate decrease in vision in the left eye (20/20 right, 20/25 left). Fundus examination revealed an atrophic left optic nerve.
Neuroimaging study (MRI of brain and orbits) revealed an extensive meningioma involving the left orbital apex (arrow).
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.